Seer, Inc.
SEER
NASDAQ·Healthcare·Biotechnology·Mkt cap $107.2M
$1.95
▲ +0.52%
P/E
-3.20
Mkt Cap
$107.2M
52-Wk Range
$1.55–$2.41
52-Week Range
$1.55 - $2.41
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 3.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Strong growth ahead
Value
Deep value opportunity - significant discount to sector peers
Momentum
Strong
+8.9% over 3m
Quality
Strong
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SEER right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 11, 2026
Reported EPS of -$0.31 vs -$0.27 consensus (-14.8% surprise). Revenue of $3.1M vs $3.5M expected (-12.6%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-14.8%
Revenue trend · last 2Q
—
-21%
Q1 26
Q2 26
$2.8M
$3.1M
Margins · last 2Q
Gross
48.5%
Profit
-544.8%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How SEER stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.